Archive: 2026/02
De facto combinations: Why taking separate generics instead of FDCs is common - and risky
Many patients take separate generic drugs instead of fixed-dose combinations (FDCs) for cost or dosing reasons. But this practice, called a de facto combination, carries hidden risks like lower adherence and untested drug interactions. Learn when it's safe - and when it's not.
Read more
Financial Toxicity in Cancer Care: How Treatment Costs Are Breaking Patients and What to Do About It
Financial toxicity in cancer care means patients face crushing costs that force them to skip treatments, go into debt, or choose between medicine and basic needs. Here's what it is, who it affects, and what you can do.
Read more
Medical Weight Management: Clinics, Medications, and Monitoring
Medical weight management combines clinics, FDA-approved medications like Wegovy and Zepbound, and ongoing monitoring to treat obesity as a chronic disease. Learn how it works, who qualifies, and why it’s more effective than diet programs.
Read more